Implementing LISA Surfactant in Nigeria

Summary

Implement surfactant (BLES®) replacement therapy using the Less Invasive Surfactant Administration technique in six tertiary institutions in Nigeria and evaluate its impact on 72-hour neonatal mortality in premature infants born less than 2000 grams at birth.

Timeline

Start

2023-06-25

Primary completion

2025-03-30

Completion

2025-03-30

Drugs

Indications